Biocryst stock news
WebAug 2, 2024 · RESEARCH TRIANGLE PARK, N.C., Aug. 02, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today the dosing of the first subject into ZENITH-1, a clinical trial ... WebMar 31, 2024 · BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Biocryst stock news
Did you know?
WebFeb 23, 2024 · BioCryst (BCRX) delivered earnings and revenue surprises of -29.03% and 2.11%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? WebFind the latest news headlines from BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) at Nasdaq.com. BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) News …
WebApr 12, 2024 · BioCryst to Present at Upcoming Investor Conferences. RESEARCH TRIANGLE PARK, N.C., April 12, 2024 (GLOBE NEWSWIRE) -- BioCryst … WebFeb 7, 2024 · PDF Version. Mar 29, 2024. BioCryst Celebrates Bob Ingram’s Contributions to the Company’s Success. PDF Version. Mar 02, 2024. BioCryst Reports Inducement …
WebNov 1, 2024 · Despite the increases in sales of Orladeyo, the company's stock finished Tuesday down 11 percent, around $11.86 a share. This is down nearly 16 percent from the beginning of the year, and below ... WebSep 5, 2024 · RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced final results from its Phase 2 APeX-1 clinical trial in hereditary ...
WebNews. Congrats, shorts & condolences, longs! Looks like BioCryst is reporting, in a very protective way, that they are seeing some sort of toxicity signal with 10013, in preclinical, animal tox data. This was their backup Factor D inhibitor that was going to be the next great thing, after 9930 was shelved. There goes the entire pipeline for the ...
WebApr 14, 2024 · In other BioCryst Pharmaceuticals news, CEO Jon P. Stonehouse sold 100,000 shares of the company's stock in a transaction that occurred on Wednesday, … shanghai immigration lawyerWebApr 8, 2024 · RBC Capital analyst Brian Abrahams maintained a Hold rating on BioCryst ( BCRX – Research Report) on April 6 and set a price target of $9.00. The company’s shares closed last Thursday at $8.68 ... shanghai income tax calculatorWebApr 6, 2024 · BioCryst Pharmaceuticals, Inc. (BioCryst) is a commercial-stage biotechnology company that discovers small-molecule medicines. The Company focus on oral treatments for rare diseases in which unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease. ORLADEYO (berotralstat) is an … shanghai immigration officeWebGet the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock news and headlines to help you in your trading and investing decisions. shanghai immigration addressWebMar 29, 2024 · Stock Information. Stock Quote & Chart; Historic Stock Lookup; Investment Calculator; Finance & Filings. ... Recent News. Stay up to date with the latest discoveries, events, and reports from BioCryst. April 12, 2024 BioCryst to Present at Upcoming Investor Conferences April 4, 2024 shanghai import and export commodity fairWebApr 6, 2024 · finance.yahoo.com - February 21 at 9:36 AM. Why BioCryst Pharmaceuticals Stock Is Sliding Today. benzinga.com - February 21 at 9:36 AM. BioCryst Pharmaceuticals Non-GAAP EPS of -$0.38 misses by $0.18, revenue of $79.5M beats by $5.32M. msn.com - February 21 at 9:36 AM. shanghai immigrationWebMay 21, 2024 · During the first three months of 2024, sales of the injection reached an annualized rate of $3.2 billion. So for BioCryst, capturing just a fraction of the … shanghai import export